Close Menu

NEW YORK (GenomeWeb) — Adial Pharmaceuticals said today that it has signed on Eurofins Scientific to help validate a companion diagnostic for its alcohol use disorder drug AD04 and identify patients for enrollment in a Phase III trial.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 


This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.